No Detail Found!

Comparison of efficacy & safety of blue light vs topical application of 1% clindamycin solution in the treatment of mild to moderate inflammatory acne vulgaris

Author(s)
SAIRA MOHSIN Zahida Walfare Hospital, Lahore, Pakistan
MUHAMMAD NADEEM Dermatology, Sir Ganga Ram Hospital, Lahore, Pakistan
SHAHBAZ AMAN Dermatology, Services Institute of Medical Sciences/Services Hospital, Lahore, Pakistan
ZAIB Dermatology, DHQ Teaching Hospital/ Sargodha Medical College, Sargodha, Pakistan
SHEHBAZ ALI Alkhidmat Teaching Mansoorah Hospital, Lahore, Pakistan
Abstract
Aim: To compare the efficacy & safety of blue light vs topical application of 1% clindamycin solution in the treatment of mild to moderate inflammatory acne vulgaris. Study Design: Comparative interventional study done in Dermatology Outpatient Department Unit-II, KEMU/ Mayo Hospital, Lahore six months i.e. 1-06-2014 - 30-11-2014 Methodology: After an informed and written consent, 130 patients fulfilling the selection criteria were enrolled in the study and divided in two study groups A & B by balloting method. At first visit, a detailed history and clinical examination was recorded on a specially designed proforma. The acne was graded according to the acne grading scale of American Academy of Dermatology.4,13 Group A was exposed to blue light for twenty minutes twice weekly for eight weeks. Group B was given 1% clindamycin to apply twice daily for a period of eight weeks. Post- treatment follow up was done for next four weeks. Patients were assessed at 2nd, 4th, 6th, 8th, 10th, and 12th week. All findings and side effects were recorded on a predesigned proforma. To determine the efficacy of treatment, Acne Severity Index (ASI) was used.5 Result: Efficacy of treatment [= 50% improvement in ASI score] was seen in 39(60%) patients in blue light group while in clindamycin group it was achieved in 8 (12.3%) patients only. Blue light group had significantly less number of side effects observed in 35 (37.23%) patients while clindamycin group had a higher number of side effects observed in 59 (62.77%) patients, p-value= 0.013. Conclusion: Blue light is more efficacious and safer than topical 1% clindamycin in the treatment of mild to moderate inflammatory acne vulgaris.
Publication Details
Page(s) 1475-1480
Published Journal: Pakistan Journal of Medical and Health Sciences, Volume: 15, Issue: 7, Year: 2021

Request the full text from PASTIC

Keywords
acne vulgaris, blue light, 1% Clindamycin
0

Citations

0

Downloads

89

Views